Pharma Journalist -

Kite, a Gilead Company and Arcellx, Inc. announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for the…
Read More...

Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that Health Canada has approved Empaveli™ (pegcetacoplan), a complement inhibitor, for the…
Read More...

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
Read More...

Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™)…
Read More...

300+ C-suite and board level leaders from NYU Langone, Sutter Health, Memorial Hermann, UCI Health and others will unite in San Diego on May 16-17, to force radical change over two…
Read More...

Akero Therapeutics, Inc. a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced that…
Read More...

VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that Health Canada has approved PreHevbrio…
Read More...

Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, announces a development and supply agreement with Odimma Therapeutics, a French…
Read More...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has approved a…
Read More...

Pfizer Inc. and Clear Creek Bio, Inc. announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the…
Read More...